ANTIC: A phase 2, prospective, randomised, open, blinded end-point (PROBE), controlled, cross-over, multi-centre, nutritional interventional study in chronic obstructive pulmonary disease (COPD)

 

 Trial Summary:

The aim of this study is to identify one or more promising nutrition interventions targeting the gut-lung axis to reduce inflammation in COPD.

 

This study will also be aiming to determine the effect of diet on gut microbiome.

Supported By:

NHMRC 2021 Synergy Grant

Eligibility:

Adults with chronic obstructive pulmonary disease (COPD)

Registration ID:

Pending

Participation:

Australia

Status:

In start up

Activation Date:

Pending

Chair:

 Professor Meg Jardine, Dr Jessica Dawson

Contact:

antic.study@sydney.edu.au